Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.20.2
Consolidated Balance Sheets - USD ($)
Aug. 31, 2020
Nov. 30, 2019
Current Assets    
Cash and cash equivalents $ 8,107,608 $ 6,541,037
Marketable securities 62,716 904,053
Accounts receivable (net of allowance for doubtful accounts of $2,772,550 and $2,584,091, respectively) 6,503,550 6,097,331
Prepaid expenses 599,429 500,260
Inventory, current portion 1,203,328 1,084,533
Other current assets 287,032 260,397
Total current assets 16,763,663 15,387,611
Property and Equipment-net 1,663,892 1,846,467
Other Assets    
Intangible assets, net 1,198,504 1,249,254
Inventory, net of current portion 12,289,477 12,646,000
Goodwill 1,941,411 1,941,411
Deferred tax assets 9,079,994 9,079,994
Operating lease right-of-use asset 365,696  
Deposits and other assets, net 479,526 427,423
Total other assets 26,012,608 25,652,082
Total assets 44,440,163 42,886,160
Current Liabilities    
Accounts payable 899,951 1,369,111
Accrued expenses 1,048,762 2,085,180
Current portion of note payable 3,100,000 3,100,000
Current portion of operating lease liability 271,932  
Deferred revenue 9,107,027 8,875,138
Total current liabilities 14,427,672 15,429,429
Other Liabilities    
Deferred revenue, net of current portion 26,201,441 23,633,373
Contingent consideration 3,280,316 3,495,057
Note payable, net of current portion and debt issuance costs 3,598,164 5,856,152
Operating lease long-term liability 93,904  
Long-term liability - revenue sharing agreements 875,000 1,425,000
Total other liabilities 34,048,825 34,409,582
Total liabilities 48,476,497 49,839,011
Commitments and contingencies (Note 10) 0 0
Stockholders' Deficit    
Preferred stock 0 0
Common stock ($.01 par value, 20,000,000 authorized; 13,633,638 issued and 7,545,613 outstanding as of August 31, 2020 and 13,598,909 issued and 7,510,884 outstanding as of November 30, 2019) 136,336 135,989
Additional paid-in capital 36,410,226 35,918,827
Treasury stock, at cost (20,563,357) (20,563,357)
Accumulated deficit (20,019,539) (22,444,310)
Total stockholders' deficit (4,036,334) (6,952,851)
Total liabilities and stockholders' deficit 44,440,163 42,886,160
Series A Junior Participating Preferred Stock [Member]    
Stockholders' Deficit    
Preferred stock 0 0
Tianhe Stem Cell Biotechnologies Inc [Member]    
Other Assets    
Investment 308,000 $ 308,000
Patent Option Agreement [Member]    
Other Assets    
Investment $ 350,000